7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Darpan D, Joshi G, Amrutkar SM, Baviskar AT, Kler H, Singh S, Banerjee UC, Kumar R. Synthesis and biological evaluation of new 2,5-dimethylthiophene/furan based N-acetyl pyrazolines as selective topoisomerase II inhibitors Rsc Advances. 6: 14880-14892. DOI: 10.1039/C5Ra25705K  0.716
2015 Negi A, Alex JM, Amrutkar SM, Baviskar AT, Joshi G, Singh S, Banerjee UC, Kumar R. Imine/amide-imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via selective topoisomerase-II-α inhibition. Bioorganic & Medicinal Chemistry. PMID 26216018 DOI: 10.1016/J.Bmc.2015.07.020  0.714
2015 Baviskar AT, Amrutkar SM, Trivedi N, Chaudhary V, Nayak A, Guchhait SK, Banerjee UC, Bharatam PV, Kundu CN. Switch in Site of Inhibition: A Strategy for Structure-Based Discovery of Human Topoisomerase IIα Catalytic Inhibitors. Acs Medicinal Chemistry Letters. 6: 481-5. PMID 25941559 DOI: 10.1021/Acsmedchemlett.5B00040  0.662
2013 Baviskar AT, Banerjee UC, Gupta M, Singh R, Kumar S, Gupta MK, Kumar S, Raut SK, Khullar M, Singh S, Kumar R. Synthesis of imine-pyrazolopyrimidinones and their mechanistic interventions on anticancer activity. Bioorganic & Medicinal Chemistry. 21: 5782-93. PMID 23920485 DOI: 10.1016/j.bmc.2013.07.016  0.347
2013 Kashyap M, Kandekar S, Baviskar AT, Das D, Preet R, Mohapatra P, Satapathy SR, Siddharth S, Guchhait SK, Kundu CN, Banerjee UC. Indenoindolone derivatives as topoisomerase II-inhibiting anticancer agents. Bioorganic & Medicinal Chemistry Letters. 23: 934-8. PMID 23321564 DOI: 10.1016/J.Bmcl.2012.12.063  0.704
2013 Singh S, Baviskar AT, Jain V, Mishra N, Chand Banerjee U, Bharatam PV, Tikoo K, Singh Ishar MP. 3-Formylchromone based topoisomerase IIα inhibitors: discovery of potent leads Medchemcomm. 4: 1257. DOI: 10.1039/C3MD00125C  0.482
2011 Baviskar AT, Madaan C, Preet R, Mohapatra P, Jain V, Agarwal A, Guchhait SK, Kundu CN, Banerjee UC, Bharatam PV. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase. Journal of Medicinal Chemistry. 54: 5013-30. PMID 21644529 DOI: 10.1021/Jm200235U  0.709
Show low-probability matches.